{"id":"NCT00078286","sponsor":"Duke University","briefTitle":"Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure","officialTitle":"Safety and Efficacy of Sertraline for Depression CHF","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2003-11","primaryCompletion":"2008-03","completion":"2008-09","firstPosted":"2004-02-24","resultsPosted":"2013-02-27","lastUpdate":"2013-02-27"},"enrollment":469,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Heart Failure, Congestive","Chronic Heart Failure","Depression"],"interventions":[{"type":"DRUG","name":"Sertraline","otherNames":["Zoloft"]},{"type":"DRUG","name":"Placebo","otherNames":["Inactive pill"]}],"arms":[{"label":"Sertraline","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study will examine the effect of antidepressant medication on rates of death and disease in depressed people with chronic heart failure.","primaryOutcome":{"measure":"Symptoms of Depression in Congestive Heart Failure Patients With Clinical Depression After Treatment With Sertraline or Placebo","timeFrame":"Measured at Week 12","effectByArm":[{"arm":"Sertraline","deltaMin":-7.1,"sd":0.5},{"arm":"Placebo","deltaMin":-6.8,"sd":0.5}],"pValues":[{"comp":"OG000 vs OG001","p":"0.89"}]},"eligibility":{"minAge":"45 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":7},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["20723799","26186432","20101071","18760123"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":57,"n":234},"commonTop":["Congestive Heart Failure","Other Cardiovascular","Unstable Angina"]}}